The frequency and association of C609T and C465T polymorphisms of NAD(P)H: Quinone oxidoreductase gene with adult acute myeloid leukemia

Laboratory Medicine

Volumn 42, Issue 11, 2011, Pages 674-677

  Zaker, Farhad ^a   Safaei, Akram ^b   Hashemi, Mehrdad ^b   Pazhakh, Vahid ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Acute myeloid leukemia; NQO1; Polymorphisms; RLFP

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84855522999     PISSN: 00075027     EISSN: 19437730     Source Type: Journal    
DOI: 10.1309/LMNTBFPIASMWI1RT     Document Type: Article

References (26)

1. McPherson RA, Pincus MR. Henry's Clinical Diagnosis and Management by Laboratory Methods. 21st ed. Philadelphia, PA: WB Saunders; 2007:558.
2. Pazhakh V, Razmkhah F, Zaker F, et al. Methylenetetrahydrofolate reductase gene polymorphisms and risk of myeloid leukemia. Lab Med. 2010;41:490-494.
3. Skibola CF, Smith MT, Kane E, et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci U S A. 1999;96:12810-12815.
4. Aydin-Sayitoglu M, Hatirnaz O, Erensoy N, et al. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias. Am J Hematol. 2006;81:162-170.
5. Majumdar S, Mondal BC, Ghosh M, et al. Association of cytochrome P450, glutathione S-transferase and N-acetyl transferase 2 gene polymorphisms with incidence of acute myeloid leukemia. Eur J Cancer Prev. 2008;17:125-132.
6. Ernster L. DT-diaphorase: Its structure, function, regulation, and role in antioxidant defense and cancer chemotherapy. In: Yagi K, ed. Pathophysiology of Lipid Peroxides and Related Free Radicals. Basel, Switzerland: S. Karger; 1998:149.
7. Ross D, Kepa JK, Winski SL, et al. NAD(P)H:quinone oxidoreductase 1(NQO1): Chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem Biol Interact. 2000;129:77-97.
8. Traver RD, Siegel D, Beall HD, et al. Characterization of a polymorphism in NAD(P)H: Quinone oxidoreductase (DT-diaphorase). Br J Cancer. 1997;75:69-75.
9. Malik E, Cohen SB, Sahar D, et al. The frequencies of NAD(P)H quinone oxidoreductase (NQO1) variant allele in Israeli ethnic groups and the relationship of NQO1*2 to adult acute myeloid leukemia in Israeli patients. Haematologica. 2006;91:956-959.
10. Eguchi-Ishimae M, Eguchi M, Ishii E, et al. The association of a distinctive allele of NAD (P) H: quinone oxidoreductase with pediatric acute lymphoblastic leukemias with MLL fusion genes in Japan. Haematologica. 2005;90:1511-1515.
11. Rothman N, Smith MT, Hayes RB, et al. Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C→T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res. 1997;57:2839-2842.
12. Eastmond DA, Smith MT, Irons RD. An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure. Toxicol Appl Pharmacol. 1987;91:85-95.
13. Smith MT, Yager JW, Steinmetz KL, et al. Peroxidase-dependent metabolism of benzene's phenolic metabolites and its potential role in benzene toxicity and carcinogenicity. Environ Health Perspect. 1989;82:23-29.
14. Lan Q, Zhang L, Li G, et al. Hematotoxicity in workers exposed to low levels of benzene. Science. 2004;306:1774-1776.
15. Wan J, Shi J, Hui L, et al. Association of genetic polymorphisms in CYP2E1, MPO, NQO1, GSTM1, and GSTT1 genes with benzene poisoning. Environ Health Perspect. 2002;110:1213-1218.
16. Bolufer P, Collado M, Barragán E, et al. The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia. Haematologica. 2007;92:308-314.
17. Larson RA, Wang Y, Banerjee M, et al. Prevalence of the inactivating 609C→T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood. 1999;94:803-807.
18. Smith MT, Wang Y, Kane E, et al. Low NAD(P)H: quinone oxidoreductase I activity is associated with an increased risk of acute leukemia in adults. Blood. 2001;97:1422-1426.
19. Naoe T, Takeyama K, Yokozawa T, et al. Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res. 2000;6:4091-4095.
20. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
21. Biramijamal F, Sanati MH, Banoei M, et al. Genetic polymorphism analysis of NAD(P)H: quinone oxidoreductase 1 in different Iranian ethnic groups. Current Science. 2006;91:1065-1068.
22. Wiencke JK, Spitz MR, McMillan A, et al. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD (P) H: quinone oxidoreductase polymorphism. Cancer Epidemiol Biomarkers Prev. 1997;6:87-92.
23. Kelsey KT, Ross D, Traver RD, et al. Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy. Br J Cancer. 1997;76:852-854.
24. von Ahsen N, Richter M, Grupp C, et al. No influence of the MDR-1 C435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporine A trough concentrations or rejection incidence in stable renal transplant recipients. Clin Chem. 2001;47:1048-1052.
25. Reynolds WF, Chang E, Douer D, et al. An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia. Blood. 1997;90:2730-2737.
26. Ganousis LG, Goon D, Zyglewska T, et al. Cell-specific metabolism in mouse bone marrow stroma: Studies of activation and detoxification of benzene metabolites. Mol Pharmacol. 1992;42:1118-1125.